drugset / Trial / NCT03077282
Safety of Prasaprohyai 95%Ethanolic Extract Capsules in Healthy Volunteer
RandomizedParallel-groupOpen-labelTreatment
Summary
To investigate the safety of Prasaprohyai 95% ethanolic extract at doses of 100 mg and 200 mg for for 6 weeks. (Clinical Trial phase I)
Timeline
- Start
- 2018-04-26
- Primary completion
- 2018-12-01
- Completion
- 2018-12-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prasaprohyai | Unknown | 100 mg | Oral |
| Subject | Prasaprohyai | Unknown | 200 mg | Oral |
Indications
No indication recorded.